Laboratory Assessment Tool

Similar documents
Laboratory accreditation

ENIVD CODE OF CONDUCT for Outbreak Assistance Laboratories. CHECKLIST of major issues to address before departure and during the mission

Guidelines for Preventive and Social Medicine/Community Medicine/Community Health Curriculum in the Undergraduate Medical Education

Regional meeting of directors of national blood transfusion services

Working document QAS/ RESTRICTED September 2006

DISEASE SURVEILLANCE AND RESPONSE PROGRAMME AREA DISEASE PREVENTION AND CONTROL CLUSTER

REPOSITIONING OUR CLINICAL LABORATORIES FOR EFFECTIVE AND EFFICIENT HEALTHCARE DELIVERY. By Prof. Ibironke Akinsete Chairman PathCare Nigeria

2017 APHL BIOSAFETY AND BIOSECURITY SURVEY

Strategy of TB laboratories for TB Control Program in Developing Countries

STANDARDS Point-of-Care Testing

JANUARY Evaluation of Impact of CBEP Training Activities on the Performance of Targeted Laboratories in Iraq

Joint external evaluation of IHR Core Capacities of the Republic of Uganda. Executive summary June 26-30, 2017

Analysis in the light of the Health 2020 strategy By Roberto Bertollini, Celine Brassart and Chrysoula Galanaki

2016 APHL BIOSAFETY AND BIOSECURITY SURVEY

Biological Weapons Convention Meeting of Experts. Geneva, Switzerland August WHO's. Dr Nicoletta Previsani

Advancing Biosafety Across the U.S. Clinical Laboratory Community

Regional consultation on the availability and safety of blood transfusion during humanitarian emergencies

Standards for Laboratory Accreditation

TRAINING. A. Hazard Communication/Right-to-Know Training

Strengthening nursing and midwifery in the Eastern Mediterranean Region

Asia Pacific Strategy for Strengthening Health Laboratory Services ( )

The WHO laboratory network to enhance laboratory biosafety and biosecurity in developing countries

GLOBAL HEALTH SECURITY AGENDA ROADMAP FOR ETHIOPIA

AUDIT UNDP BOSNIA AND HERZEGOVINA GRANTS FROM THE GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS AND MALARIA. Report No Issue Date: 15 January 2014

Assuring Laboratory Biosecurity

Informal note on the draft outline of the report of WHO on progress achieved in realizing the commitments made in the UN Political Declaration on NCDs

Grant Aid Projects/Standard Indicator Reference (Health)

BIOSECURITY IN THE LABORATORY

SOP WP6-QUAL-04, Version 1.0, 23 February 2014 Page 1 of 8. SOP Title: Laboratory (GCLP) supervision visits

Joint External Evaluation. of the Democratic Socialist Republic of Sri Lanka. Mission report: June 19-23, 2017

VIRGINIA TECH INSTITUTIONAL BIOSAFETY COMMITTEE

A university wishing to have an accredited program in adult Infectious Diseases must also sponsor an accredited program in Internal Medicine.

Safety in Laboratories: Indian Scenario

ESSENTIAL HEALTH TECHNOLOGIES

Conclusion: what works?

Improving Patient Safety: First Steps

Regulatory,Quality & Emergency Preparedness. MaryBeth Parache Director, Quality Affairs New York Blood Center

Biological Agents and Toxins Act: Development and Enforcement of Biosafety and Biosecurity in Singapore

Ebola Preparedness and Response in Ghana

Accreditation of Clinical Laboratories

NLTC-9. Supporting Your Sentinel Laboratories

POCKET GUIDE TO THE ACCREDITATION STANDARDS (ISO 15189:2014)

Planning meeting to set up a diploma in mental health, human rights and law at the International Islamic University, Islamabad, Pakistan

Establishing a Public Health Laboratory System. The Namibian Experience

MEDICAL LABORATORIES - REQUIREMENTS FOR ACCREDITATION ACCORDING TO SM SR EN ISO 15189:2014

AMERICAN BOARD OF HISTOCOMPATIBILITY AND IMMUNOGENETICS Laboratory Director. Content Outline

Institute for Quality Management in Healthcare (IQMH) Toronto, Ontario, Canada. Janice Nolan, Executive Director, Programs

USAID s Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program ( )

Administration OCCUPATIONAL HEALTH AND SAFETY

EU/ACP/WHO RENEWED PARTNERSHIP

IHR Core Capacities Overview and Monitoring

<3Al ftshop. Report No AB52. Updated Project Information Document (PID)

STRENGTHENING NATIONAL IMPLEMENTATION

Viral Load Scale-Up Clinical Facility Readiness Assessment

SOUTH EASTERN TRUST. Point of Care Testing (POCT) Policy Ellie Duly, Chair POCT Committee. Approval date: Operational Date: November 2014

2 WHO: World Health Organization 3 ISO: International Organization for Standardization

Revised forms for the submission of the Confidence-Building Measures

National Blood Policy. National AIDS Control Organisation Ministry of Health and Family Welfare Government of India New Delhi

EBOLA- THEN; NOW and FUTURE SIERRA LEONE

ASSEMBLY BILL No. 940

The registration department at Kuwait Drug and Food Control Administration (KDFCA) monitors and

Prof. Dr. Hasan Abbas Zaheer Project Director Safe Blood Transfusion Services Programme Pakistan

Tailoring Immunization Programmes (TIP): Outputs of pilot implementation in Bulgaria

US ): [42CFR ]:

GOVERNMENT OF THE REPUBLIC OF SIERRA LEONE MINISTRY OF HEALTH AND SANITATION. National Infection Prevention and Control Policy

Towards Quality Care for Patients. National Core Standards for Health Establishments in South Africa Abridged version

Assessment of Awareness Level about Bio Risk Management among Staff of Different Academic Laboratories

Joint Commission International Accreditation Standards for Hospitals. Including Standards for Academic Medical Center Hospitals

Level 5 Diploma in Occupational Health and Safety Practice ( )

CLIA s New IQCP Requirements Are in Effect, or Are They?: Implementing Laboratory Risk Management Now to Ensure Success

World Federation for Culture Collections ICCC-12 Conference Florianopolis, Brazil, 26 Sept 1 Oct Dr Nicoletta Previsani

Guideline: Administrative & Logistic Arrangement in Supporting The Joint Multi-Sectoral Outbreak Investigation & Response in ASEAN

Readiness Checklist for Plague V Country: Date:

National Health Strategy

READVERTISED. Call for Proposals

Dominic Cox Royal Free Hospital London Joan Pearson Leeds General Infirmary

Content Sheet 11-1: Overview of Norms and Accreditation

Safety Culture in Life Sciences Laboratories: Time for Action. Donald R. Callihan

ECDC Fellowship Programme

Guidelines for Accreditation of Medical Schools in Countries of the South-East Asia Region

ORISSA STATE AIDS CONTROL SOCIETY (Department of Health & Family Welfare), Government of Orissa

Table of Contents. Page ii

Health and Nutrition Public Investment Programme

African Partnerships for Patient Safety. Evaluation Handbook April 2012

Meeting the Challenges of Global Laboratory Systems Development: Human Resources Capacity Development

GLOBAL HEALTH SECURITY AGENDA: ACTION PACKAGE PREVENT-3 BIOSAFETY AND BIOSECURITY ASSESSMENT

Training Requirements for the Specialty of Medical Microbiology

Regulatory Control of Diagnostics in Tanzania. Hiiti Sillo Ag. Director General Tanzania Food and Drugs Authority

Towards Quality Care for Patients. Fast Track to Quality The Six Most Critical Areas for Patient-Centered Care

Dr. AM Abdullah Inspector General, MOH THE HEALTH SITUATION IN IRAQ 2009

DEMOCRATIC PEOPLE S REPUBLIC OF KOREA

NZS/ISO 15189:2007. Medical Laboratories Particular Requirements for Quality and Competence NZS/ISO 15189:2007

Radiation Safety Code of Practice

THE CALIFORNIA STATE UNIVERSITY Office of the Chancellor 400 Golden Shore Long Beach, CA (562)

QUALITY ASSURANCE IN LABORATORY PRACTICES (Working Paper for the Technical Discussions)

JOINT PLAN OF ACTION in Response to Cyclone Nargis

Guide to Incident Reporting for In-vitro Diagnostic Medical Devices

Draft Version Presentation Draft

POL:00:QP:001:03:NIBT PAGE 1 of 8. Document Details Document Number: POL:00:QP:001:03:NIBT No. of Appendices: 1 Supersedes Number: 00:02:QP:001:NIBT

Toolkit for assessing health-system capacity for crisis management

Transcription:

WHO/HSE/GCR/LYO/2012.2 Laboratory Assessment Tool Annex 1: Laboratory Assessment Tool / System Questionnaire April 2012 World Health Organization 2012 All rights reserved. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use.

Table of content General 1 Coordination and management 2 Structure and organization 8 Regulations 13 Quality of laboratory system 16 Laboratory management 24 Infrastructure 26 Human resources 27 Biorisk management 32 Gap analysis 36 Summary 39 Acronyms 40

Annex 1: LAT/System - General 1 General Country assessed Date of the assessment (DD/MM/YYYY) Name and contact details of the assessor List name/s, contact details and level/s of authority of key interviewed person/s Comments

Annex 1: LAT/System - Coordination and management 2 1. Coordination and management Possible answers (unless otherwise advised): 1.Yes; 2.Partial; 3.No; 4.Non applicable Coordination 1.1 Does the relevant Ministry have a dedicated unit in charge of health laboratory coordination? 1.2 If yes, please provide name/s, terms of reference and contact details of the unit and responsible person/s X 1.3 Is there an official decree/text establishing the health laboratory coordination unit and defining terms of reference? X 1.4 Has this unit a dedicated budget? 1.5 Has this unit developed coordination mechanisms with disease-specific control programmes? 1.6 Has this unit an oversight role of reference laboratory designation and operations? 1.7 Does this unit participate in public health-related committees such as influenza preparedness committees, emergency committees, or immunization committees? 1.8 Does the coordinating unit coordinate its activities with the Ministry of Agriculture or its relevant agencies?

Annex 1: LAT/System - Coordination and management 3 1.9 Do the coordinating unit coordinate their activities with the Ministry of Environment or its relevant agencies? 1.10 Does the coordinating unit coordinate its activities with the Ministry of Education about laboratory worker education? 1.11 Has this unit an oversight role of private laboratory regulations and operations? 1.12 Is the unit assisted by an advisory body (committee or commission)? 1.13 If yes, please provide terms of reference and composition of the body X 1.14 Is there a national policy for health laboratory services defining the goals and objectives of the national laboratory system? X If yes or partial, does the policy address: 1.15 Laboratory service coordination and leadership? 1.16 Laboratory service structure and organization? 1.17 Laboratory service testing capacity?

Annex 1: LAT/System - Coordination and management 4 1.18 Laboratory service networking mechanisms? 1.19 Laboratory service role in public health? 1.20 Laboratory service regulatory framework? 1.21 Laboratory service quality assurance framework? 1.22 Laboratory workforce? 1.23 Laboratory equipement and reagent procurement and supplying systems? 1.24 Laboratory service funding? 1.25 Is there a strategic plan aiming at strengthening laboratory services or other strategic plan/s with a laboratory component? X 1.26 If yes or partial, please briefly describe main components of the plan

Annex 1: LAT/System - Coordination and management 5 1.27 Is the plan funded and implemented? 1.28 Are there indicators to monitor laboratory services (as part of the strategic plan monitoring or separately from the plan)? X 1.29 If yes or partial, please list these indicators Funding How are the laboratory services funded (for each source, specify percentage of funding)? 1.30 Government or public health insurance 1.31 User's fees 1.32 Donors 1.33 Other (specify)

Annex 1: LAT/System - Coordination and management 6 1.34 Is there a specific budget assigned for public health laboratory activities (such as reference laboratories and networks operations)? 1.35 Has a cost-effectiveness analysis been performed to select technically and financially appropriate laboratory technologies and methods? X 1.36 Are testing prices regulated? If yes, are testing prices recommended by: 1.37 A national regulation/legislation? 1.38 Public health insurance system (social security)? 1.39 Private health insurance system? Equipment and supply management 1.40 Please describe the procurement system/s for public laboratories (centralized or decentralized purchasing and storage, bulk or small purchasing, quality of supplies, suppliers' location, etc.) and provide all necessary documents X

Annex 1: LAT/System - Coordination and management 7 1.41 Please describe the procurement system/s for private laboratories (centralized or decentralized purchasing and storage, bulk or small purchasing, quality of supplies, suppliers' location, etc.) and provide all necessary documents X 1.42 Do disease-specific control programmes (e.g. TB, malaria) use specific procurement systems? 1.43 Are there national guidelines on laboratory equipment donations? 1.44 Are coordination mechanisms established with donors for equipment and supply donation or procurement? 1.45 Do the donors or partners (e.g. NGOs, international organizations, foundations) follow national regulations for equipment or supply procurement (e.g. distribution of qualified IVD devices only)? Comments

Annex 1: LAT/System - Structure and organization 8 2. Structure and organization Possible answers (unless otherwise advised): 1.Yes; 2.Partial; 3.No; 4.Non applicable Structure 2.1 Is organizational structure of the laboratory services clearly defined with lines of authority? 2.2 If yes, please provide and comment any related charts or documents X 2.3 Are the laboratories organized in a tiered system with different levels of functions? 2.4 Is there an inventory or directory of laboratories performing clinical testing (health centre, hospital, public health, academic, research, etc.) in the country? X 2.5 Does this inventory take into account private clinical laboratories? 2.6 What kind of is recorded for each laboratory (contact details, testing capacity, staff number, etc.)?

Annex 1: LAT/System - Structure and organization 9 Please estimate the number of laboratories within the following definitions: 2.7 Central/national/reference laboratories 2.8 Intermediate laboratories (regional or provincial level) 2.9 Peripheral laboratories (district or health centre level) Reference laboratories 2.10 Are reference laboratories identified for priority diseases or public health threats? 2.11 If yes or partial, please provide the list of reference laboratories (e.g. TB, HIV) X 2.12 Are these reference laboratories officially designated (e.g. by directive, by regulation, by national authorities)? X 2.13 Are reference laboratories part of a national early warning system in place for public health events/outbreaks?

Annex 1: LAT/System - Structure and organization 10 2.14 Do representatives from reference laboratories routinely participate in outbreak or public health event preparedness and management meetings? 2.15 Do representatives from reference laboratories routinely participate in field investigations during public health events (e.g. outbreaks)? Networking mechanisms 2.16 Are laboratories organized in network/s for clinical testing purposes (e.g. access to specialized or confirmatory testing that is not available at the patient location)? 2.17 If yes or partial, please describe for each network: member laboratory names or types, networking mechanisms (especially how samples and data are shared across the networks), documentation developed (SOPs, testing algorithm, reports forms) and funding sources 2.18 Are laboratories organized in networks for public health or surveillance purposes? 2.19 If yes or partial, please describe for each network: member laboratory names or types, networking mechanisms (especially how samples and data are shared across the networks), documentation developed (SOPs, testing algorithm, reports forms) and funding sources

Annex 1: LAT/System - Structure and organization 11 2.20 Are private laboratories part of the surveillance network/s? 2.21 If yes, is participation of private laboratories mandatory, imposed by law, through contractual agreement, etc.? 2.22 Are these network/s officially designated (e.g. by directive, by regulation, by national authorities)? 2.23 Are reference laboratories members of international networks? 2.24 If yes or partial, please provide the list of laboratories and networks 2.25 Are there standardized reporting form/s for laboratory data within and across network/s? X 2.26 Is there a stock of emergency sample collection and transport supplies (personal protective equipment, sample collection material, transport media)?

Annex 1: LAT/System - Structure and organization 12 If yes, where are they positioned/stored? 2.27 Central/reference level 2.28 Intermediate level 2.29 Peripheral level Comments

Annex 1: LAT/System - Regulations 13 3. Regulations Possible answers (unless otherwise advised): 1.Yes; 2.Partial; 3.No; 4.Non applicable 3.1 Do public laboratories need to be registered or licensed to operate? 3.2 Do private laboratories need to be registered or licensed to operate? 3.3 Please describe any registration and/or licensing criteria X 3.4 If applicable, is the license/work authorization delivered after an initial on-site visit? 3.5 If applicable, is the license/work authorization periodically reviewed? 3.6 How is the compliance with licensing criteria ensured (describe any inspection or control mechanism)?

Annex 1: LAT/System - Regulations 14 Are the following areas regulated (as part of licensing mechanism or separately): 3.7 Laboratory facilities? 3.8 Equipment? 3.9 Staff? 3.10 In vitro diagnostic medical device qualification? 3.11 Sample transportation? 3.12 Testing methods? 3.13 Data management? 3.14 Biorisk management measures?

Annex 1: LAT/System - Regulations 15 3.15 Laboratory related ethics? 3.16 Are legislation and regulations regularly evaluated and updated to maintain relevance for evolving national and international needs? Comments

Annex 1: LAT/System - Quality of laboratory system 16 4. Quality of laboratory system Possible answers (unless otherwise advised): 1.Yes; 2.Partial; 3.No; 4.Non applicable National standardization 4.1 Is there a national laboratory quality office for oversight of national laboratory quality programmes? X 4.2 If yes, name and contact details of the office/responsible person/s 4.3 Please briefly describe the national quality programme/s in place 4.4 Are national general quality norms/sets of standards established? X If yes or partial, do they address these topics: 4.5 Laboratory organization and management? 4.6 Documentation and records?

Annex 1: LAT/System - Quality of laboratory system 17 4.7 Specimen collection and transport? 4.8 SOPs for specimen processing? 4.9 Personnel and education requirements? 4.10 Biorisk management? 4.11 Equipment, reagents, reference materials, consumables management? 4.12 Collaboration with referral laboratories? 4.13 Internal quality control procedures? 4.14 External quality assessment procedures? 4.15 Data and management?

Annex 1: LAT/System - Quality of laboratory system 18 4.16 Are more specific quality standards available through membership of defined networks (e.g. TB, HIV)? In case laboratory services are organized in tiered network: 4.17 Are minimal equipments standardized for each laboratory level? X 4.18 Are minimal staff number and qualifications standardized for each laboratory level? X 4.19 Are tests performed and methods standardized for each laboratory level? X 4.20 Please describe how and by whom norms and standards are developed (e.g. by standardization body, professional societies, specialized networks, reference laboratories) Quality assessment 4.21 Is there a national body in charge of laboratory inspection?

Annex 1: LAT/System - Quality of laboratory system 19 4.22 If yes, please describe the inspection mechanism (frequency, procedures, sanctions, etc.) 4.23 Is there a national body in charge of laboratory certification (e.g. using ISO 9001)? 4.24 If yes, please provide name/s: 4.25 Is there a national body in charge of laboratory accreditation (e.g. using ISO 15189)? 4.26 If yes, please provide name/s: 4.27 If no, do laboratories use services of foreign national or regional accreditation bodies? 4.28 If yes, please provide name/s: 4.29 Are some laboratories accredited for disease-specific testing by WHO (e.g. polio, measles, HIV genotyping)?

Annex 1: LAT/System - Quality of laboratory system 20 4.30 Please provide number of laboratories certified or accredited and specify to which standard 4.31 Is there a specific national document which describes the registration procedure for in vitro diagnostic medical devices (IVD, i.e. kits and reagents)? X 4.32 Is there a national regulatory authority responsible for in vitro diagnostic device (e.g. reagents) qualification or registration? 4.33 If yes, please provide a summary of the qualification or registration mechanisms X 4.34 Besides the inspection, certification or accreditation detailed above is any other kind of supervision organized? 4.35 If yes or partial, describe the supervision plan and procedures (e.g. through specific networks like TB control programme or surveillance programmes) X 4.36 Are there standardized supervision checklists or procedures? X 4.37 When supervised, do the laboratories receive a report after each supervision? X

Annex 1: LAT/System - Quality of laboratory system 21 4.38 Are there indicators to measure the progress in laboratory test quality? 4.39 Please list these indicators Does your country have a national EQA programme (proficiency-testing or rechecking) in the following areas: 4.40 Bacteriology? 4.41 Virology? 4.42 Serology? 4.43 Parasitology? 4.44 Biochemistry

Annex 1: LAT/System - Quality of laboratory system 22 4.45 Haematology? 4.46 Anatomical pathology? 4.47 Cytogenetic? 4.48 Transfusion medicine? 4.49 Please describe the national EQA programme/s organization by providing for each: name of the programme, contact person/s, one line of description 4.50 If applicable, is participation in national EQA programmes/s mandatory for public laboratories? 4.51 If applicable, is participation in national EQA programmes/s mandatory for private laboratories? 4.52 Percentage of public laboratories participating in the national EQA scheme (EQAS):

Annex 1: LAT/System - Quality of laboratory system 23 4.53 Percentage of private laboratories participating in the national EQAS: 4.54 Are corrective actions organized when assessment result is poor? X Comments

Annex 1: LAT/System - Laboratory management 24 5. Laboratory management Possible answers (unless otherwise advised): 1.Yes; 2.Partial; 3.No; 4.Non applicable 5.1 Does the MoH laboratory coordination unit collect any laboratory data? 5.2 If yes or partial, please describe which kind of data (tests ordered and/or performed, logistics data, scientific data, etc.) and data collection mechanisms X 5.3 Are standardized forms available to collect these data? X 5.4 Does the MoH use a computerized Laboratory Information System (LIS) to collect and analyse data? 5.5 Is this LIS connected to the MoH Health Information System? X 5.6 If yes, describe how 5.7 Does the MoH laboratory coordination unit share data with other agencies or units?

Annex 1: LAT/System - Laboratory management 25 5.8 If yes or partial, please describe which data and for which purpose 5.9 Does the MoH laboratory coordination unit ensure feedback to the laboratory community? 5.10 If yes, please describe the communication mechanisms and procedures (e.g. newsletter, website) Comments

Annex 1: LAT/System - Infrastructure 26 6. Infrastructure Possible answers (unless otherwise advised): 1.Yes; 2.Partial; 3.No; 4.Non applicable 6.1 Are there any requirements in terms of building and facilities for laboratory operations (e.g. cold storage, containment requirements)? 6.2 Is the facility infrastructure generally satisfactory throughout the country (i.e. ensuring quality of work and safety of staff)? 6.3 Is there any national plan or project to build, renovate or upgrade laboratory facilities? 6.4 If yes, describe laboratory concerned, objectives and funding sources Comments

Annex 1: LAT/System - Human resources 27 7. Human resources Possible answers (unless otherwise advised): 1.Yes; 2.Partial; 3.No; 4.Non applicable Staff 7.1 Is there an inventory of laboratory workers? X 7.2 Is the overall number of laboratory workers sufficient for the healthcare needs? 7.3 Is the laboratory staff well distributed within the country in accordance with the needs? 7.4 Is the education/training/experience of laboratory workers in accordance with the needs of the work? 7.5 Is the salary of laboratory workers appropriate for the work? 7.6 Are most laboratory workers national staff (as compared with workers from other countries)? 7.7 Does the country graduate adequate number of trained personnel for its needs? 7.8 Are there trained biomedical engineers/technicians (for specific laboratory equipment maintenance) inside the country?

Annex 1: LAT/System - Human resources 28 7.9 Is qualified staff easily maintained in laboratory in the country? 7.10 If no, please list the difficulties 7.11 Is the licensing/registration of laboratory workers organized? X 7.12 If yes, please describe the licensing/registration requirements 7.13 How many people are licensed/registered as laboratory workers? 7.14 If applicable, is continuous education/training mandatory to renew staff work authorization? Education Are national specific degrees delivered for: 7.15 Laboratory technicians? 7.16 Post-graduate clinical pathologists?

Annex 1: LAT/System - Human resources 29 7.17 Post-graduate medical microbiologists? 7.18 If yes, please provide name/s of these degree/s and associated curricula: 7.19 Are these degrees mandatory for working in a medical laboratory? 7.20 Are there interministerial mechanisms involving health and education ministries to review and adapt training curricula according to the needs? X 7.21 Do laboratory workers have access to suitable continuous education/training? Is continuous education available in the following areas: 7.22 Specimen collection, packaging and transportation? 7.23 Laboratory quality assurance? 7.24 New laboratory diagnostic techniques?

Annex 1: LAT/System - Human resources 30 7.25 Data management? 7.26 Epidemiological surveillance? 7.27 Field Epidemiology and Laboratory Training Programme? 7.28 Computer science applied to laboratory? 7.29 Biorisk management? 7.30 Laboratory management? 7.31 How are these courses provided (manufacturing companies, professional societies, distance learning, face-to-face, etc.)?

Annex 1: LAT/System - Human resources 31 Comments

Annex 1: LAT/System - Biorisk management 32 8. Biorisk management Possible answers (unless otherwise advised): 1.Yes; 2.Partial; 3.No; 4.Non applicable 8.1 Does the relevant ministry have a dedicated unit in charge of biosafety/biosecurity at national level? 8.2 If yes, name and contact details of the unit/responsible person/s X 8.3 Have biological risks and pathogens been identified, classified and listed at the national level? X 8.4 Does a national up-to-date legislation define minimal biosafety levels, measures or requirements for operation? 8.5 If yes, please describe them shortly and provide relevant documentation X 8.6 Are specific policy or regulation for waste management and disposal available?

Annex 1: LAT/System - Biorisk management 33 8.7 If yes, please describe them shortly and provide relevant documentation X 8.8 Are inspections of laboratories performed by national authorities to evaluate compliance with biosafety requirement? 8.9 Does the country have functional BSL-3 laboratories to deal with highly dangerous pathogens? 8.10 If yes, number of functional BSL-3 laboratories: 8.11 Please also provide the number of functional BSL-4 laboratories: 8.12 Are the new facilities formally commisioned before opening? 8.13 Can the biosafety cabinets (BSC) be certified by local certification bodies?

Annex 1: LAT/System - Biorisk management 34 8.14 Is there a specific national document for specimen packaging and transportation? X 8.15 If yes, is its application mandatory by law or decree? 8.16 Are specific packages (like triple packages complying with P620 and P650 requirements) available? 8.17 If yes, from which source/s? Local suppliers, foreign suppliers, external assistance (e.g. NGO, UN) 8.18 Are national regulations in place and up-to-date for the transport of infectious substances (Categories A and B)? X 8.19 Do local carriers ensure the transport of infectious substances according to the national requirements? 8.20 Are infectious substances (Categories A and B) imported or exported from/to other countries? 8.21 Do central/reference laboratories have access to express courier service/s (e.g. DHL, FedEx, World Courier)? 8.22 Do the people responsible for the shipment of specimens have access to training on infectious substance transport?

Annex 1: LAT/System - Biorisk management 35 8.23 If yes, are these trainings in line with United Nations regulations on the transport of infectious substances? 8.24 Do laboratory staff have access to occupational/worker health services in all facilities? 8.25 Is there a specific vaccination policy (pre-exposure prophylaxis) for laboratory workers (Hepatitis B and other relevant diseases)? X 8.26 Are vaccines that have been identified as mandatory provided to laboratory workers? 8.27 Is post-exposure prophylaxis treatment provided to laboratory workers in all facilities? Comments

Annex 1: LAT/System - Gap analysis 36 9. Gap analysis What are the biggest needs/weaknesses of the national laboratory system? Score from 0 (no gap) to 5 (high gap) for the items below and please provide comments for the area/s that display the biggest weaknesses (scores 4 and 5) 0; ; 5 Comments 9.1 Financial resources for laboratory activities 9.2 Human resources qualifications and availability of suitable laboratory staff 9.3 Equipment adequacy 9.4 Reagent and consumable quality 9.5 National guidelines on specific laboratory practices 9.6 Collection of specimens 9.7 Transportation of specimens

Annex 1: LAT/System - Gap analysis 37 9.8 Laboratory organization, service delivery structure, and networking 9.9 Regulatory framework 9.10 Laboratory safety or security 9.11 Quality assurance 9.12 Recognition of importance of laboratory services 9.13 Political commitment (national laboratory policies, budget, etc.) 9.14 Other For other, please specify:

Annex 1: LAT/System - Gap analysis 38 Comments

Annex 1: LAT/System - Summary 39 Laboratory System Assessment Questionnaire Report General comments on the assessment Conclusions and recommendations

Annex 1: LAT/System - Acronyms 40 Acronyms referred to in this document BSC BSL EQA EQAS HIV HR ISO IVD LIS MoH NGO SOP TB UN WHO Biosafety Cabinet Biosafety Level External Quality Assessment External Quality Assessment Scheme Human Immunodeficiency Virus Human Resources International Organization for Standardization In vitro diagnostic medical devices Laboratory Information System Ministry of Health Non-Governmental Organization Standard Operating Procedure/s Tuberculosis United Nations World Health Organization